Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 2 (3), e209

Asymmetries of Poverty: Why Global Burden of Disease Valuations Underestimate the Burden of Neglected Tropical Diseases

Affiliations

Asymmetries of Poverty: Why Global Burden of Disease Valuations Underestimate the Burden of Neglected Tropical Diseases

Charles H King et al. PLoS Negl Trop Dis.

Abstract

The disability-adjusted life year (DALY) initially appeared attractive as a health metric in the Global Burden of Disease (GBD) program, as it purports to be a comprehensive health assessment that encompassed premature mortality, morbidity, impairment, and disability. It was originally thought that the DALY would be useful in policy settings, reflecting normative valuations as a standardized unit of ill health. However, the design of the DALY and its use in policy estimates contain inherent flaws that result in systematic undervaluation of the importance of chronic diseases, such as many of the neglected tropical diseases (NTDs), in world health. The conceptual design of the DALY comes out of a perspective largely focused on the individual risk rather than the ecology of disease, thus failing to acknowledge the implications of context on the burden of disease for the poor. It is nonrepresentative of the impact of poverty on disability, which results in the significant underestimation of disability weights for chronic diseases such as the NTDs. Finally, the application of the DALY in policy estimates does not account for the nonlinear effects of poverty in the cost-utility analysis of disease control, effectively discounting the utility of comprehensively treating NTDs. The present DALY framework needs to be substantially revised if the GBD is to become a valid and useful system for determining health priorities.

Conflict of interest statement

Dr. King is a Deputy Editor of PLoS Neglected Tropical Diseases.

Figures

Figure 1
Figure 1. The DALY Person-Trade-Off Method of Disability Weight Determination.
Figure 2
Figure 2. “Asymmetrical” or Nonlinear Outlook on Program Costs and Health Gains.
To someone in the setting of severe poverty (income < $1 per day), the gain or loss of a single health or performance-related dollar will appear substantially more important than it will to a middle-income policymaker.
Figure 3
Figure 3. In the Context of Poverty There Are Nonlinear Differences in the Efficacy of Treatment on Health Outcomes.
Individual poverty and residence in an impoverished environment can combine synergistically to impair improvement from single health interventions. (See reference .)

Similar articles

See all similar articles

Cited by 57 PubMed Central articles

See all "Cited by" articles

References

    1. Hoos IR. Societal aspects of technology assessment. Technol Forecast Soc Change. 1979;13:191–202.
    1. Jamison DT. Investing in health. In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M et al., editors. Disease control priorities in developing countries. Washington (D.C.): Oxford University Press and The World Bank; 2006. pp. 3–34.
    1. Mathers CD, Ezzati M, Lopez AD. Measuring the burden of neglected tropical diseases: the global burden of disease framework. PLoS Negl Trop Dis. 2007;1:e114. doi:10.1371/journal.pntd.0000114. - PMC - PubMed
    1. Stein C, Kuchenmüller T, Hendrickx S, Prüss-Ustün A, Wolfson L, et al. The Global burden of disease assessments - WHO is responsible? PLoS Negl Trop Dis. 2007;1:e161. doi:10.1371/journal.pntd.0000161. - PMC - PubMed
    1. Singer BH, Ryff CD. Neglected tropical diseases, neglected data sources, and neglected issues. PLoS Negl Trop Dis. 2007;1:e104. doi:10.1371/journal.pntd.0000104. - PMC - PubMed

Publication types

Feedback